MedPath

The efficacy of Papaverine Hydrochloride with Diclofenac Na in the treatment of acute renal colic

Phase 3
Conditions
Renal colic.
Unspecified renal colic
Registration Number
IRCT138808251853N4
Lead Sponsor
Vice-chancellor for Research, Guilan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
550
Inclusion Criteria

age 15-55 years, symptoms of renal colic with any of the followings: hematuria detected by urine analysis, calculi detected by Genitourinary radiography or by sonography.
Exclusion criteria: complete AV block, coronary artery disease, bronchial asthma, peptic ulcer disease, coagulopathy, anticougulat therapy, sensitivity to Dicolofenac or papaverin, renal or liver insufficiency, pregnancy, breast feeding, receiving any analgesics in the past 4 hours.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Renal colic pain. Timepoint: 10 month. Method of measurement: questionairre.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath